Concepedia

Booster Dose Efficacy

Booster Dose Efficacy is a vaccine efficacy metric that quantifies the incremental improvement in immune protection following the administration of an additional dose after completion of the primary vaccination series.

925

Publications

48.1K

Citations

9.4K

Authors

1.9K

Institutions

Publications per year

2017–2026

485

Parents

Publications

925

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial

The Lancet · 2015 · 1.5K citations · Full text

, , +16

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

Yinon M. Bar‐On, Yair Goldberg, Micha Mandel et al. · New England Journal of Medicine · 2021 · 1.2K citations · Full text

, , +17

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

, , +16

Hepatitis B Vaccine

W. Szmuness, Cladd E. Stevens, Edward J. Harley et al. · New England Journal of Medicine · 1980 · 1.1K citations

, , +17

Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study

Noam Barda, Noa Dagan, Cyrille J. Cohen et al. · The Lancet · 2021 · 941 citations · Full text

, , +17

1–5 of 925

Authors

9.4K

  1. AJ
    Andrew J. Pollard

    University of Oxford, United Kingdom

    16 publications · 1.9K citations

    15

    h-index

  2. MD
    Matthew D. Snape

    University of Oxford, United Kingdom

    15 publications · 1.9K citations

    14

    h-index

  3. RL
    Ruth Link‐Gelles

    Centers for Disease Control and Prevention, United States

    14 publications · 1.9K citations

    13

    h-index

  4. MG
    Manjusha Gaglani

    Baylor Scott & White Health, United States

    13 publications · 1.6K citations

    12

    h-index

  5. JM
    Jacqueline M. Miller

    Moderna Therapeutics (United States), United States

    15 publications · 1.6K citations

    12

    h-index

1–5 of 9.4K

Institutions

1.9K

  1. GlaxoSmithKline (Belgium)

    Wavre, Belgium

    21 h-index

    112 publications

    4.1K citations

  2. London School of Hygiene & Tropical Medicine

    London, United Kingdom

    20 h-index

    89 publications

    7.2K citations

  3. University of Oxford

    Oxford, United Kingdom

    20 h-index

    363 publications

    68.1K citations

  4. Tel Aviv University

    Tel Aviv, Israel

    20 h-index

    170 publications

    10.2K citations

  5. Centers for Disease Control and Prevention

    Atlanta, United States

    18 h-index

    109 publications

    9.4K citations

  6. University College London

    London, United Kingdom

    16 h-index

    69 publications

    4.5K citations

  7. Johns Hopkins University

    Baltimore, United States

    15 h-index

    92 publications

    5K citations

  8. Istituti di Ricovero e Cura a Carattere Scientifico

    Rome, Italy

    13 h-index

    175 publications

    10K citations

1–8 of 1.9K

Venues

  1. Vaccine

    71 publications · 2.3K citations

    28

    h-index

  2. The Journal of Infectious Diseases

    JID · 34 publications · 2.7K citations

    26

    h-index

  3. The Pediatric Infectious Disease Journal

    PIDJ · 47 publications · 2.4K citations

    26

    h-index

  4. PubMed

    Repository · 49 publications · 1.5K citations

    25

    h-index

  5. Vaccines

    38 publications · 1.2K citations

    20

    h-index

1–5